Galderma Readies Its First Therapeutic Biologic For Two US Launches In 2024

Phase III Data Also Show New Toxin Works Up To Six Months

 
• By Mandy Jackson
  
Wooden blocks with launching rocket graphic arranged in pyramid shape
Galderma is building up to its nemolizumab launch in the US next year • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Dermatological

More from Therapeutic Category